Still another aspect of the invention is a pharmaceutical composition comprising an anti-Stat1 antibody, an anti-Stat2 antibody, an anti-Stat3 antibody, an anti-Stat4 antibody, an anti-SOCS1 antibody, an anti-SOCS3 antibody and a pharmaceutically acceptable carrier.